Guest Lecture on "Development of a novel, first-in-class drug product, PMZ-1620, for patients with cerebral ischemic stroke " by Dr. Anil Gulati, Associate Dean and Professor of Pharmacology, Midwestern University, Chicago & Chairman, Board of Directors-Pharmazz, Inc. USA (January 9, 2019)